Concerns Rise Over Medicare's $50 Weight-loss Drug Coverage

WHO:

Inc - Medicare beneficiaries will be able to access weight-loss drugs.

NBC News Health - Dr. John Torres is a medical contributor discussing the program.

WHAT:

Inc - Medicare will cover weight-loss drugs like Wegovy and Zepbound for the first time.

NBC News Health - A new pilot program will allow Medicare Part D beneficiaries to access weight-loss drugs at a significantly reduced price.

WHERE:

Inc - The program is applicable to Medicare beneficiaries across the United States.

WHEN:

Inc - There is a deadline for the program set for 2027.

WHY:

Inc - Experts express concern that a strict BMI checklist may limit access to the program.

HOW:

NBC News Health - The program will provide access to popular weight-loss drugs at a reduced price for a limited time.

(UPDATED June 30, 2026 17:39 UTC)

Medicare will soon cover weight-loss drugs like Wegovy and Zepbound for the first time, allowing beneficiaries across the United States to access these medications at a significantly reduced price through a new pilot program. Medical contributor Dr. John Torres discussed this initiative, which aims to help Medicare Part D beneficiaries but has raised concerns among experts about a strict BMI checklist potentially limiting access. The program is set to have a deadline in 2027, providing a limited-time opportunity for those eligible to benefit from these weight-loss drugs.